Literature DB >> 27270438

p27Kip1 represses the Pitx2-mediated expression of p21Cip1 and regulates DNA replication during cell cycle progression.

E Gallastegui1, A Biçer1, S Orlando1, A Besson2,3,4, M J Pujol1, O Bachs1.   

Abstract

The tumor suppressor p21 regulates cell cycle progression and peaks at mid/late G1. However, the mechanisms regulating its expression during cell cycle are poorly understood. We found that embryonic fibroblasts from p27 null mice at early passages progress slowly through the cell cycle. These cells present an elevated basal expression of p21 suggesting that p27 participates to its repression. Mechanistically, we found that p27 represses the expression of Pitx2 (an activator of p21 expression) by associating with the ASE-regulatory region of this gene together with an E2F4 repressive complex. Furthermore, we found that Pitx2 binds to the p21 promoter and induces its transcription. Finally, silencing Pitx2 or p21 in proliferating cells accelerates DNA replication and cell cycle progression. Collectively, these results demonstrate an unprecedented connection between p27, Pitx2 and p21 relevant for the regulation of cell cycle progression and cancer and for understanding human pathologies associated with p27 germline mutations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27270438     DOI: 10.1038/onc.2016.200

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

Review 2.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 3.  Hox gene regulation and timing in embryogenesis.

Authors:  Thomas Montavon; Natalia Soshnikova
Journal:  Semin Cell Dev Biol       Date:  2014-06-12       Impact factor: 7.727

4.  Tbx1 regulates progenitor cell proliferation in the dental epithelium by modulating Pitx2 activation of p21.

Authors:  Huojun Cao; Sergio Florez; Melanie Amen; Tuong Huynh; Ziedonis Skobe; Antonio Baldini; Brad A Amendt
Journal:  Dev Biol       Date:  2010-09-15       Impact factor: 3.582

5.  Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma.

Authors:  Yan Liu; Yue Huang; Guo-Zhang Zhu
Journal:  Mol Cell Biochem       Date:  2013-09-04       Impact factor: 3.396

6.  Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2.

Authors:  Yue Huang; Celine J Guigon; Jun Fan; Sheue-yann Cheng; Guo-Zhang Zhu
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

7.  The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit.

Authors:  Sabrina L Spencer; Steven D Cappell; Feng-Chiao Tsai; K Wesley Overton; Clifford L Wang; Tobias Meyer
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

8.  P21 functions to maintain quiescence of p27-deficient hepatocytes.

Authors:  Young Hye Kwon; Aleksandra Jovanovic; Michael S Serfas; Hiroaki Kiyokawa; Angela L Tyner
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

Review 9.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.

Authors:  Isabel M Chu; Ludger Hengst; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

10.  Dosage requirement of Pitx2 for development of multiple organs.

Authors:  P J Gage; H Suh; S A Camper
Journal:  Development       Date:  1999-10       Impact factor: 6.868

View more
  5 in total

1.  Organic extract of Geodia cydonium induces cell cycle block in human mesothelioma cells.

Authors:  Francesco Di Meo; Roberta Esposito; Rossana Cuciniello; Gregorio Favale; Mario Arenga; Nadia Ruocco; Genoveffa Nuzzo; Angelo Fontana; Stefania Filosa; Stefania Crispi; Maria Costantini
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

2.  Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.

Authors:  Verena Sailer; Heidrun Gevensleben; Joern Dietrich; Diane Goltz; Glen Kristiansen; Friedrich Bootz; Dimo Dietrich
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

3.  p27Kip1 regulates alpha-synuclein expression.

Authors:  Edurne Gallastegui; Carla Domuro; Joan Serratosa; Alejandra Larrieux; Laura Sin; Jonatan Martinez; Arnaud Besson; José Manuel Morante-Redolat; Serena Orlando; Rosa Aligue; Isabel Fariñas; María Jesús Pujol; Oriol Bachs
Journal:  Oncotarget       Date:  2018-03-27

4.  ChIP-Seq analysis identifies p27(Kip1)-target genes involved in cell adhesion and cell signalling in mouse embryonic fibroblasts.

Authors:  Atilla Biçer; Serena Orlando; Abul B M M K Islam; Edurne Gallastegui; Arnaud Besson; Rosa Aligué; Oriol Bachs; Maria Jesús Pujol
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

Review 5.  Role of p27Kip1 as a transcriptional regulator.

Authors:  Oriol Bachs; Edurne Gallastegui; Serena Orlando; Anna Bigas; José Manuel Morante-Redolat; Joan Serratosa; Isabel Fariñas; Rosa Aligué; Maria Jesús Pujol
Journal:  Oncotarget       Date:  2018-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.